Literature DB >> 18784149

High-resolution computed tomography and scleroderma lung disease.

A U Wells1.   

Abstract

High-resolution CT has now become an important part of the routine detection and evaluation of interstitial lung disease in SSc. CT now has a central role in the detection of interstitial disease, largely because other modalities have been unsatisfactory in this regard. Historically, CT has also been used to identify a high likelihood of reversible inflammatory disease in SSc, based upon studies in other diffuse lung diseases. However, accumulated evidence indicates that ground-glass attenuation on CT is not a reliable indicator of underlying alveolitis. Ground-glass attenuation on CT is common in SSc but reversible disease is found at surgical biopsy in a minority of cases, and is rare when ground glass is associated with reticular abnormalities or traction bronchiectasis. Furthermore, ground glass regresses inconsistently on serial CT evaluation, with or without treatment. CT is more useful in the staging of disease extent. Although formal CT scoring is not realistic in routine practice, rapid semi-quantitative estimation of disease extent on CT in combination with a forced vital capacity threshold has been used to stage disease as limited or extensive. The distinction between a higher and lower risk of progression of lung disease, made using this system, has important implications for both routine practice and the enrolment of higher risk patients in therapeutic studies.

Entities:  

Mesh:

Year:  2008        PMID: 18784149     DOI: 10.1093/rheumatology/ken271

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

Review 1.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Authors:  Theodoros Dimitroulas; Sophie Mavrogeni; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

2.  Utility of an open-source DICOM viewer software (OsiriX) to assess pulmonary fibrosis in systemic sclerosis: preliminary results.

Authors:  Alarico Ariani; Marina Carotti; Marwin Gutierrez; Elisabetta Bichisecchi; Walter Grassi; Gian Marco Giuseppetti; Fausto Salaffi
Journal:  Rheumatol Int       Date:  2013-08-15       Impact factor: 2.631

3.  Automated 3D ιnterstitial lung disease εxtent quantification: performance evaluation and correlation to PFTs.

Authors:  Alexandra Kazantzi; Lena Costaridou; Spyros Skiadopoulos; Panayiotis Korfiatis; Anna Karahaliou; Dimitris Daoussis; Andreas Andonopoulos; Christina Kalogeropoulou
Journal:  J Digit Imaging       Date:  2014-06       Impact factor: 4.056

4.  Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.

Authors:  Jonathan G Goldin; Grace Hyun J Kim; Chi-Hong Tseng; Elizabeth Volkmann; Daniel Furst; Philip Clements; Matt Brown; Michael Roth; Dinesh Khanna; Donald P Tashkin
Journal:  Ann Am Thorac Soc       Date:  2018-11

5.  Quantitative volumetric assessment of pulmonary involvement in patients with systemic sclerosis.

Authors:  Mehmet Güli Çetinçakmak; Cemil Göya; Cihad Hamidi; Güven Tekbaş; Özlem Abakay; İbrahim Batmaz; Salih Hattapoğlu; Alpaslan Yavuz; Aslan Bilici
Journal:  Quant Imaging Med Surg       Date:  2016-02

Review 6.  Tomography patterns of lung disease in systemic sclerosis.

Authors:  Andréa de Lima Bastos; Ricardo de Amorim Corrêa; Gilda Aparecida Ferreira
Journal:  Radiol Bras       Date:  2016 Sep-Oct

Review 7.  Imaging lung disease in systemic sclerosis.

Authors:  Diane Strollo; Jonathan Goldin
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

Review 8.  [Interstitial lung disease in collagen vascular diseases. Diagnostic and therapeutic implications of non-specific interstitial pneumonia].

Authors:  A Schnabel; M Reuter
Journal:  Z Rheumatol       Date:  2009-10       Impact factor: 1.372

9.  Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study.

Authors:  Jonathan Goldin; Robert Elashoff; Hyun J Kim; Xaiohong Yan; David Lynch; Diane Strollo; Michael D Roth; Philip Clements; Daniel E Furst; Dinesh Khanna; Srainnapha Vasunilashorn; Gang Li; Donald P Tashkin
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

10.  Diagnostic performances of high resolution trans-thoracic lung ultrasonography in pulmonary alveoli-interstitial involvement of rheumatoid lung disease.

Authors:  Miramir Aghdashi; Behdad Broofeh; Afshin Mohammadi
Journal:  Int J Clin Exp Med       Date:  2013-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.